Volume 17, Issue 1 (2-2025)                   IJDO 2025, 17(1): 1-9 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Izanlou M, Djazayery A, Keshavarz S A. Effects of a Multi-Strain Supplement Combination Lactobacillus and Bifidobacterium on Anthropometric Measurements and Body Fat Percentage in Adults with Overweight and Obesity. IJDO 2025; 17 (1) :1-9
URL: http://ijdo.ssu.ac.ir/article-1-929-en.html
PhD, Professor Emeritus of Nutrition, Department of Nutrition, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Abstract:   (83 Views)
Objective: Probiotics are living microorganisms that play a part in energy balance. One of the most important causes of obesity is dysbiosis in the intestinal microbiota composition. This study aimed to determine the effects of a multi-strain probiotic supplement containing Lactobacillus and Bifidobacterium on anthropometric measurements and body fat percentage in adults with overweight and obesity.
Materials and Methods: This was a randomized trial including 74 overweight and obese adults referring to two private clinics who entered the study after signing a written informed consent. Participants were randomly assigned to either group and received either 1×109 CFU/day probiotic capsule or a placebo for 12 weeks. They were advised not to change their usual diet or physical activity during the study period. Anthropometric measurements, body fat percentage, dietary intake, and physical activity were assessed both at first and 12 weeks of the treatment.
Results: The intervention group showed significant differences in the mean body weight (-1.46 kg), body mass index (-0.54 kg/m2), waist circumference (-1.24cm), hip circumference (-0.42cm), waist-to-hip ratio (-0.01), and fat percentage (-0.66%) compared to their baseline values (all P< 0.001), but there were no significant differences in comparison with the placebo group (P> 0.05). In the placebo group there were negligible non-significant effects on body weight, body mass index and waist circumference.
Conclusion: The findings of this study showed that probiotic supplementation containing several strains of Lactobacillus and Bifidobacterium can improve anthropometric measurements and body fat percentage in adults.
 
Full-Text [PDF 740 kb]   (79 Downloads)    
Type of Study: Research | Subject: Special
Received: 2024/12/12 | Accepted: 2025/01/20 | Published: 2025/02/27

References
1. Obesity Canada Clinical Practice Guidelines Expert Panel. Assessment of people living with obesity. 2020 Available from: URL https://obesitycanada. ca/guidelines/assessment/. Accessed 2023 December 5.
2. WHO Obesity and Overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/ obesity-and-overweight. Accessed 2024 March 1.
3. Pouraram H, Djazayery A, Mohammad K, Parsaeian M, Abdollahi Z, Motlagh AD, et al. Second national integrated micronutrient survey in Iran: Study design and preliminary findings. Archives of Iranian medicine. 2018;21(4):137-44.
4. Kim TN. Barriers to obesity management: patient and physician factors. Journal of Obesity & Metabolic Syndrome. 2020;29(4):244-7. [DOI:10.7570/jomes20124]
5. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proceedings of the national academy of sciences. 2005;102(31):11070-5. [DOI:10.1073/pnas.0504978102]
6. Cani PD, Van Hul M, Lefort C, Depommier C, Rastelli M, Everard A. Microbial regulation of organismal energy homeostasis. Nature metabolism. 2019;1(1):34-46. [DOI:10.1038/s42255-018-0017-4]
7. Heiss CN, Olofsson LE. Gut microbiota-dependent modulation of energy metabolism. Journal of innate immunity. 2018;10(3):163-71. [DOI:10.1159/000481519]
8. Marvasti FE, Moshiri A, Taghavi MS, Riazi S, Taati M, Sadati SF, et al. The first report of differences in gut microbiota composition between obese and normal weight Iranian subjects. Iranian biomedical journal. 2019;24(3):148.-54. [DOI:10.29252/ibj.24.3.148]
9. Noble EE, Hsu TM, Kanoski SE. Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive impairment. Frontiers in behavioral neuroscience. 2017;11:9. [DOI:10.3389/fnbeh.2017.00009]
10. Sanz Y, Moya-Pérez A. Microbiota, inflammation and obesity. Microbial endocrinology: The microbiota-gut-brain axis in health and disease. 2014:291-317. [DOI:10.1007/978-1-4939-0897-4_14]
11. Noor J, Chaudhry A, Batool S, Noor R, Fatima G. Exploring the impact of the gut microbiome on obesity and weight loss: a review article. Cureus. 2023;15(6):e40948. [DOI:10.7759/cureus.40948]
12. WHO Report on Joint FAO/WHO Guidelines for the Evaluation of Probiotics in Food. Accessed 2022 August 3. Available from:https:// openknowledge.fao.org/server/api/core/bitstreams/382476b3-4d54-4175-803f-2f26f3526256/content
13. Kobyliak N, Conte C, Cammarota G, Haley AP, Styriak I, Gaspar L, et al. Probiotics in prevention and treatment of obesity: a critical view. Nutrition & metabolism. 2016;13:1-3. [DOI:10.1186/s12986-016-0067-0]
14. Choi MJ, Yu H, Kim JI, Seo H, Kim JG, Kim SK, et al. Anti-obesity effects of Lactiplantibacillus plantarum SKO-001 in high-fat diet-induced obese mice. European Journal of Nutrition. 2023;62(4):1611-22. [DOI:10.1007/s00394-023-03096-x]
15. Wang M, Zhang B, Hu J, Nie S, Xiong T, Xie M. Intervention of five strains of Lactobacillus on obesity in mice induced by high-fat diet. Journal of Functional Foods. 2020;72:104078. [DOI:10.1016/j.jff.2020.104078]
16. Yoon Y, Kim G, Noh MG, Park JH, Jang M, Fang S, et al. Lactobacillus fermentum promotes adipose tissue oxidative phosphorylation to protect against diet-induced obesity. Experimental & Molecular Medicine. 2020;52(9):1574-86. [DOI:10.1038/s12276-020-00502-w]
17. Caimari A, del Bas JM, Boqué N, Crescenti A, Puiggròs F, Chenoll E, et al. Heat-killed Bifidobacterium animalis subsp. Lactis CECT 8145 increases lean mass and ameliorates metabolic syndrome in cafeteria-fed obese rats. Journal of functional foods. 2017;38:251-63. [DOI:10.1016/j.jff.2017.09.029]
18. Chen J, Chen X, Ho CL. Recent development of probiotic bifidobacteria for treating human diseases. Frontiers in bioengineering and biotechnology. 2021;9:770248. [DOI:10.3389/fbioe.2021.770248]
19. Lyu Q, Chen RA, Chuang HL, Zou HB, Liu L, Sung LK, et al. Bifidobacterium alleviate metabolic disorders via converting methionine to 5'-methylthioadenosine. Gut Microbes. 2024;16(1):2300847. [DOI:10.1080/19490976.2023.2300847]
20. Kang Y, Cai Y. The development of probiotics therapy to obesity: a therapy that has gained considerable momentum. Hormones. 2018;17:141-51. [DOI:10.1007/s42000-018-0003-y]
21. Daniali M, Nikfar S, Abdollahi M. A brief overview on the use of probiotics to treat overweight and obese patients. Expert review of endocrinology & metabolism. 2020;15(1):1-4. [DOI:10.1080/17446651.2020.1719068]
22. Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. .World applied sciences journal. 2012;18(8):1073-80.
23. Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World journal of gastroenterology. 2021;27(25):3837-50. [DOI:10.3748/wjg.v27.i25.3837]
24. Ejtahed HS, Hoseini Tavassol Z, Hasani-Ranjbar S, Soroush AR, Siadat SD, Larijani B. Gut Microbiota Composition in Obese and Normal Weight Adults in Iran. Journal of Mazandaran University of Medical Sciences. 2021 Jan 10;30(193):12-20.(in Persian)
25. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541-6. [DOI:10.1038/nature12506]
26. Cerdó T, García-Santos JA, G. Bermúdez M, Campoy C. The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients. 2019;11(3):635. [DOI:10.3390/nu11030635]
27. Cunningham AL, Stephens JW, Harris DA. Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity. Journal of Diabetes & Metabolic Disorders. 2021;20(2):1855-70. [DOI:10.1007/s40200-021-00858-4]
28. Koutnikova H, Genser B, Monteiro-Sepulveda M, Faurie JM, Rizkalla S, Schrezenmeir J, et al. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. BMJ open. 2019;9(3):e017995. [DOI:10.1136/bmjopen-2017-017995]
29. Michael DR, Davies TS, Jack AA, Masetti G, Marchesi JR, Wang D, et al. Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults. Scientific reports. 2021;11(1):5. [DOI:10.1038/s41598-020-78285-3]
30. Fontaine KR, Williams MS, Hoenemeyer TW, Kaptchuk TJ, Dutton GR. Placebo effects in obesity research. Obesity (Silver Spring). 2016;24(4):769-71. [DOI:10.1002/oby.21456]
31. Chin YH, Ng CH, Chew NW, Kong G, Lim WH, Tan DJ, et al. The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis. EClinicalMedicine. 2022;54. [DOI:10.1016/j.eclinm.2022.101685]
32. Soltani S, Ashoori M, Dehghani F, Meshkini F, Clayton ZS, Abdollahi S. Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials. BMC endocrine disorders. 2023;23(1):86. [DOI:10.1186/s12902-023-01338-x]
33. Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the treatment of overweight and obesity in humans-a review of clinical trials. Microorganisms. 2020;8(8):1148. [DOI:10.3390/microorganisms8081148]
34. Park S, Bae JH. Probiotics for weight loss: a systematic review and meta-analysis. Nutrition research. 2015;35(7):566-75. [DOI:10.1016/j.nutres.2015.05.008]
35. Danielsson P, Putri RR, Marcus C, Hagman E. Evaluating probiotic efficacy on weight loss in adults with overweight through a double-blind, placebo-controlled randomized trial. Scientific Reports. 2023;13(1):18200. [DOI:10.1038/s41598-023-45395-7]

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb